Oppenheimer & CO Inc Nuvectis Pharma, Inc. Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 69,066 shares of NVCT stock, worth $471,720. This represents 0.01% of its overall portfolio holdings.
Number of Shares
69,066
Previous 41,000
68.45%
Holding current value
$471,720
Previous $400,000
28.75%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVCT
# of Institutions
48Shares Held
3.2MCall Options Held
44.5KPut Options Held
50.1K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.84 Million5.37% of portfolio
-
Iridian Asset Management LLC373KShares$2.55 Million1.01% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.95 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...